ArticleCNS neuroscience & therapeutics2026
Updating "Stroke 1-2-0" by Extending Recognition to Posterior-Circulation Stroke and Reinforcing Rapid Action in China.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Updating "Stroke 1-2-0" by Extending Recognition to Posterior-Circulation Stroke and Reinforcing Rapid Action in China.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
"Stroke 1-2-0" is a Chinese numeric mnemonic linking face drooping, arm weakness, and speech difficulty to calling emergency services (1-2-0). We propose an enhanced repeated version-"Stroke 1-2-0, Stroke 1-2-0"-that adds visual impairment and imbalance to better detect posterior-circulation strokes, while repetition may boost recall and stresses zero delay in seeking help.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.